Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Jun 5;20(7):408. doi: 10.1038/s41577-020-0360-z

Immune evasion via SARS-CoV-2 ORF8 protein?

Matthew D Park 1,
PMCID: PMC7273379  PMID: 32504060

In this preprint, Zhang et al. elucidate a potential immune evasion strategy involving the SARS-CoV-2 ORF8 protein. They show that expression of ORF8, which directly binds to MHC class I molecules, downregulates their surface expression on HEK293T cells. ORF8 co-localizes with MHC class I molecules in lysosomes, thereby disrupting antigen presentation. When healthy human donor-derived cytotoxic T lymphocytes (CTLs) sensitized to the SARS-CoV-2 epitope SSp-1 were exposed to autologous dendritic cells pre-pulsed with SSp-1, there was reduced killing of ORF8-expressing HEK293T cells compared with ORF8 non-expressing cells. These results were replicated using CTLs isolated from a patient recovering from COVID-19 that responded to a mixture of SARS-CoV-2 N and S proteins. This potential mechanism for SARS-CoV-2 evasion of host immune surveillance warrants further investigation.

Competing interests

The author declares no competing interests.

References

Original article

  1. Zhang Y, et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through potently downregulating MHC-I. bioRxiv. 2020 doi: 10.1101/2020.05.24.111823. [DOI] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES